Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Diseases (Basel, Switzerland)|November 16, 2018
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal AdenocarcinomaAshleigh Parkin, Jennifer Man, Angela Chou, et al.
Pathology|August 7, 2022
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systemsTalia L Fuchs, Angela Chou, Mahsa Ahadi, et al.
Langenbeck'S Archives of Surgery|April 25, 2026
Gastric venous congestion after pancreatic surgery: A systematic review, metanalysis and suggested protocol for assessment and managementKrishna Kotecha, Hiro Masuda, Krupa Kotecha, et al.
The Cochrane Database of Systematic Reviews|January 20, 2021
Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinomaRalph F Staerkle, Raphael Nicolas Vuille-Dit-Bille, Christopher Soll, et al.
The Medical Journal of Australia|June 20, 2016
Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensusRobert C Gandy, Andrew P Barbour, Jaswinder Samra, et al.
Plos One|July 1, 2016
Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET)Matthew H Wong, David L Chan, Adrian Lee, et al.
Neuroendocrinology|April 16, 2016
Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine TumorsAdrian Lee, David L Chan, Matthew H Wong, et al.
World Journal of Oncology|November 18, 2017
Diagnostic Accuracy of Imaging Modalities in the Evaluation of Vascular Invasion in Pancreatic Adenocarcinoma: A Meta-AnalysisAngela E Li, Bob T Li, Bernard H K Ng, et al.
Biochimica Et Biophysica Acta. General Subjects|July 15, 2020
PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progressionSumit Sahni, Christoph Krisp, Mark P Molloy, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 9, 2023
Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of greyHenry E Badgery, Tjuntu Muhlen-Schulte, John R Zalcberg, et al.
Pageof 6